Eve Health : Update - Proposed issue of securities - EVE

About this update from Eve Health Group Limited

Proposed issue of securities Update Summary Entity name For personal use only EVE HEALTH GROUP LIMITED. Announcement Type Update to previous announcement Date of this announcement 20/4/2022 Reason for update to a previous announcement Updating for approval at GM. Refer to next page for full details of the announcement Proposed issue of securities 1 / 6 Proposed issue of securities Part 1 - Entity and announcement details 1.1 Name of +Entity EVE HEALTH GROUP LIMITED. For personal use only We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules. If the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also apply for quotation of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final number of +securities issued under the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete and lodge with ASX an Appendix 2A online form notifying ASX of their issue and applying for their quotation). 1.2 Registered Number Type ABN Registration Number 89106523611 1.3 ASX issuer code EVE 1.4 The announcement is Update/amendment to previous announcement 1.4a Reason for update to a previous announcement Updating for approval at GM. 1.4b Date of previous announcement to this update 22/2/2022 1.5 Date of this announcement 20/4/2022 1.6 The Proposed issue is: A placement or other type of issue Proposed issue of securities 2 / 6 Proposed issue of securities Part 7 - Details of proposed placement or other issue For personal use only Part 7A - Conditions 7A.1 Do any external approvals need to be obtained or other conditions satisfied before the placement or other type of issue can proceed on an unconditional basis? Yes 7A.1a Conditions Approval/Condition +Security holder approval Date for determination 20/4/2022 Is the date estimated or actual? ** Approval received/condition met? Actual Yes Comments Part 7B - Issue details Is the proposed security a 'New class' (+securities in a class that is not yet quoted or recorded by ASX) or an 'Existing class' (additional securities in a class that is already quoted or recorded by ASX)? New class Details of +securities proposed to be issued Will the proposed issue of this +security include an offer of attaching +securities? No ISIN Code (if Issuer is a foreign company and +securities are non CDIs) Have you received confirmation from Will the entity be seeking quotation ASX that the terms of the proposed +securities are appropriate and equitable under listing rule 6.1? No ASX +security code New class-code to be confirmed Unlisted option exercisable at $0.005 +Security type Options of the 'new' class of +securities on ASX? No +Security description Proposed issue of securities 3 / 6 Proposed issue of securities Number of +securities proposed to be issued 466,666,667 Offer price details For personal use only Are the +securities proposed to be issued being issued for a cash consideration? No Please describe the consideration being provided for the +securities Nil consideration. The attaching options are being offered on a one for one basis to subscribers of the Placement announced 22 February 2022. Please provide an estimate of the AUD equivalent of the consideration being provided for the +securities 0.0000001 Will all the +securities issued in this class rank equally in all respects from their issue date? Yes Options details +Security currency Exercise price Expiry date AUD - Australian Dollar AUD 0.0050 31/3/2024 Details of the type of +security that will be issued if the option is exercised Other Description Unlisted options with a two year life and a $0.005 exercise price Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities proposed to be issued or provide the information by separate announcement. Part 7C - Timetable 7C.1 Proposed +issue date 21/4/2022 Proposed issue of securities 4 / 6 Proposed issue of securities Part 7D - Listing Rule requirements 7D.1 Has the entity obtained, or is it obtaining, +security holder approval for the entire issue under listing rule 7.1? Yes For personal use only 7D.1a Date of meeting or proposed meeting to approve the issue under listing rule 7.1 20/4/2022 7D.2 Is a party referred to in listing rule 10.11 participating in the proposed issue? No 7D.3 Will any of the +securities to be issued be +restricted securities for the purposes of the listing rules? No 7D.4 Will any of the +securities to be issued be subject to +voluntary escrow? No Part 7E - Fees and expenses 7E.1 Will there be a lead manager or broker to the proposed issue? No 7E.2 Is the proposed issue to be underwritten? No 7E.4 Details of any other material fees or costs to be incurred by the entity in connection with the proposed issue 6% fee paid to brokers to any placement funds raised. Part 7F - Further Information 7F.01 The purpose(s) for which the entity is issuing the securities Attaching option issued with placement shares, being used to raise funds to extend probiotic product range and working capital. 7F.1 Will the entity be changing its dividend/distribution policy if the proposed issue proceeds? No 7F.2 Any other information the entity wishes to provide about the proposed issue Proposed issue of securities 5 / 6 This is an excerpt of the original content. To continue reading it, access the original document here .

View stock analysis, news, and events for Eve Health Group Limited